Cargando…

HIV-1 latent reservoir: size matters

More than 35 million people remain infected with HIV-1. Upon antiretroviral therapy cessation, HIV-1-positive individuals systematically fail to achieve sustained virological remission, revealing the presence of a reservoir. This reservoir takes into account anatomical sanctuaries where HIV-1 contin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodel, Flavia, Patxot, Marion, Snäkä, Tiia, Ciuffi, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480782/
https://www.ncbi.nlm.nih.gov/pubmed/28757894
http://dx.doi.org/10.2217/fvl-2016-0093
_version_ 1783245304997347328
author Hodel, Flavia
Patxot, Marion
Snäkä, Tiia
Ciuffi, Angela
author_facet Hodel, Flavia
Patxot, Marion
Snäkä, Tiia
Ciuffi, Angela
author_sort Hodel, Flavia
collection PubMed
description More than 35 million people remain infected with HIV-1. Upon antiretroviral therapy cessation, HIV-1-positive individuals systematically fail to achieve sustained virological remission, revealing the presence of a reservoir. This reservoir takes into account anatomical sanctuaries where HIV-1 continues to replicate, and latently infected cells also known as the latent reservoir (LR). A better understanding of the nature and features of the LR and its quantification are crucial to evaluate the efficiency of therapeutic strategies aiming at purging HIV-1. Culture- and PCR-based assays have already been implemented to measure the LR, and new assays are continuously being developed. In this review, we will discuss these methods highlighting the difficulties to accurately measure the LR, one main obstacle in curing HIV-1.
format Online
Article
Text
id pubmed-5480782
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-54807822017-09-19 HIV-1 latent reservoir: size matters Hodel, Flavia Patxot, Marion Snäkä, Tiia Ciuffi, Angela Future Virol Review More than 35 million people remain infected with HIV-1. Upon antiretroviral therapy cessation, HIV-1-positive individuals systematically fail to achieve sustained virological remission, revealing the presence of a reservoir. This reservoir takes into account anatomical sanctuaries where HIV-1 continues to replicate, and latently infected cells also known as the latent reservoir (LR). A better understanding of the nature and features of the LR and its quantification are crucial to evaluate the efficiency of therapeutic strategies aiming at purging HIV-1. Culture- and PCR-based assays have already been implemented to measure the LR, and new assays are continuously being developed. In this review, we will discuss these methods highlighting the difficulties to accurately measure the LR, one main obstacle in curing HIV-1. Future Medicine Ltd 2016-12 2016-11-28 /pmc/articles/PMC5480782/ /pubmed/28757894 http://dx.doi.org/10.2217/fvl-2016-0093 Text en © Flavia Hodel This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review
Hodel, Flavia
Patxot, Marion
Snäkä, Tiia
Ciuffi, Angela
HIV-1 latent reservoir: size matters
title HIV-1 latent reservoir: size matters
title_full HIV-1 latent reservoir: size matters
title_fullStr HIV-1 latent reservoir: size matters
title_full_unstemmed HIV-1 latent reservoir: size matters
title_short HIV-1 latent reservoir: size matters
title_sort hiv-1 latent reservoir: size matters
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480782/
https://www.ncbi.nlm.nih.gov/pubmed/28757894
http://dx.doi.org/10.2217/fvl-2016-0093
work_keys_str_mv AT hodelflavia hiv1latentreservoirsizematters
AT patxotmarion hiv1latentreservoirsizematters
AT snakatiia hiv1latentreservoirsizematters
AT ciuffiangela hiv1latentreservoirsizematters